Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.39% | -31.48% | 27.96% | -107.52% | -148.25% |
| Total Depreciation and Amortization | -8.00% | -8.13% | -8.26% | -55.51% | 16.82% |
| Total Amortization of Deferred Charges | 26.47% | 26.16% | -40.76% | -83.52% | -80.15% |
| Total Other Non-Cash Items | 108.24% | 105.43% | -61.73% | 100.96% | 102.70% |
| Change in Net Operating Assets | 43.78% | 17,062.50% | -46.73% | -103.24% | -14.90% |
| Cash from Operations | 122.68% | 49.89% | -84.48% | -244.81% | 49.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.49% | 89.80% | -- | -100.00% | -30.64% |
| Cash from Investing | 1.49% | 89.80% | -- | 62.33% | -30.64% |
| Total Debt Issued | -42.83% | -29.47% | 50.79% | -34.79% | -10.36% |
| Total Debt Repaid | -2.90% | -25.44% | -12.29% | 68.20% | -19.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -204.73% | -51.91% | 106.76% | 4,004.00% | -52.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |